Omri Nativ

466 total citations
29 papers, 355 citations indexed

About

Omri Nativ is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Omri Nativ has authored 29 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Nephrology. Recurrent topics in Omri Nativ's work include Acute Kidney Injury Research (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Omri Nativ is often cited by papers focused on Acute Kidney Injury Research (6 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). Omri Nativ collaborates with scholars based in Israel, Italy and United States. Omri Nativ's co-authors include Ofer Nativ, Zaid Abassi, Igor Sukhotnik, Samuel N. Heyman, Boaz Moskovitz, Sarel Halachmi, Hoda Awad, Edmond Sabo, Victor Frajewicki and Alexander Kastin and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and The Journal of Urology.

In The Last Decade

Omri Nativ

26 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omri Nativ Israel 10 110 79 74 71 44 29 355
Kinga Musiał Poland 13 53 0.5× 117 1.5× 70 0.9× 208 2.9× 32 0.7× 59 488
Artur A. Antoniewicz Poland 12 114 1.0× 138 1.7× 99 1.3× 23 0.3× 13 0.3× 35 375
Yoko Azuma Japan 12 136 1.2× 117 1.5× 53 0.7× 15 0.2× 24 0.5× 58 479
Nathan Susnik Germany 12 64 0.6× 143 1.8× 74 1.0× 161 2.3× 6 0.1× 13 469
Manakan B. Srichai United States 8 69 0.6× 167 2.1× 86 1.2× 265 3.7× 40 0.9× 8 508
Shuiming Guo China 12 77 0.7× 86 1.1× 39 0.5× 61 0.9× 8 0.2× 19 384
Said Movahedi Naini United States 7 39 0.4× 118 1.5× 87 1.2× 181 2.5× 13 0.3× 8 398
Stone Yang Taiwan 15 167 1.5× 117 1.5× 106 1.4× 12 0.2× 13 0.3× 49 532
Giuseppe Carrieri Italy 11 38 0.3× 146 1.8× 157 2.1× 9 0.1× 18 0.4× 31 380
Hongya Han China 14 108 1.0× 105 1.3× 181 2.4× 56 0.8× 9 0.2× 49 535

Countries citing papers authored by Omri Nativ

Since Specialization
Citations

This map shows the geographic impact of Omri Nativ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omri Nativ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omri Nativ more than expected).

Fields of papers citing papers by Omri Nativ

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omri Nativ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omri Nativ. The network helps show where Omri Nativ may publish in the future.

Co-authorship network of co-authors of Omri Nativ

This figure shows the co-authorship network connecting the top 25 collaborators of Omri Nativ. A scholar is included among the top collaborators of Omri Nativ based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omri Nativ. Omri Nativ is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nativ, Omri, et al.. (2024). Analysis of clinical characteristics, treatment patterns, and outcome of patients with bilateral testicular germ cell tumors. Discover Oncology. 15(1). 30–30. 1 indexed citations
3.
Nativ, Omri, Safa Kinaneh, Doron Aronson, et al.. (2023). Effects of Angiotensin 1-7 and Mas Receptor Agonist on Renal System in a Rat Model of Heart Failure. International Journal of Molecular Sciences. 24(14). 11470–11470. 5 indexed citations
4.
Bejar, Jacob, et al.. (2023). Performance of CellDetect for detection of bladder cancer: Comparison with urine cytology and UroVysion. Urologic Oncology Seminars and Original Investigations. 41(6). 296.e1–296.e8. 10 indexed citations
5.
Nativ, Omri, et al.. (2022). Can Endoscopic Appearance, Selective Cytology, and Pathological Sampling During Ureteroscopy Accurately Predict Tumor Grade of Upper-Tract Urothelial Carcinoma?. Rambam Maimonides Medical Journal. 13(1). e0002–e0002. 1 indexed citations
6.
Nativ, Omri, et al.. (2022). Shock Wave Lithotripsy in Pediatric Stone Disease: A 15-Year Single-Center Experience with 2 Types of Lithotripters. Urologia Internationalis. 106(12). 1260–1264. 1 indexed citations
7.
Rosenzweig, Barak, Tima Davidson, Miki Haifler, et al.. (2022). Reply to Veerman et al. Comment on “Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410”. Journal of Personalized Medicine. 12(6). 861–861. 5 indexed citations
8.
Nativ, Omri, et al.. (2021). The additive value of mpMRI on prostate cancer detection: Comparison between patients with and without a suspicious digital rectal examination (DRE). Urologic Oncology Seminars and Original Investigations. 39(10). 728.e7–728.e11. 7 indexed citations
9.
Nativ, Omri, et al.. (2021). Idiopathic granulomatous orchitis: how can we avoid unnecessary orchiectomy?. Journal of Clinical Urology. 16(6). 701–705.
10.
Nativ, Omri, et al.. (2020). Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume. The Prostate. 80(16). 1444–1449. 60 indexed citations
11.
Aronson, Doron, et al.. (2019). Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure. Journal of Cellular and Molecular Medicine. 23(7). 4779–4794. 6 indexed citations
12.
Nativ, Omri, et al.. (2019). Risk factors predicting fever following trans-urethral prostatectomy. 2(1). 1 indexed citations
13.
Nativ, Omri, Zaher Bahouth, Edmond Sabo, et al.. (2018). Method Used for Tumor Bed Closure (Suture vs. Sealant), Ischemia Time and Duration of Surgery are Independent Predictors of Post-Nephron Sparing Surgery Acute Kidney Injury. Urologia Internationalis. 101(2). 184–189. 7 indexed citations
14.
15.
Masola, Valentina, Gianluigi Zaza, Giovanni Gambaro, et al.. (2016). Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. PLoS ONE. 11(7). e0160074–e0160074. 52 indexed citations
16.
Hussein, Osamah, Omri Nativ, Hoda Awad, et al.. (2015). Effects of phosphodiesterase-5 inhibitor on ischemic kidney injury during nephron sparing surgery: quantitative assessment by NGAL and KIM-1. World Journal of Urology. 33(12). 2053–2062. 16 indexed citations
17.
Sukhotnik, Igor, et al.. (2012). Methotrexate induces germ cell apoptosis and impairs spermatogenesis in a rat. Pediatric Surgery International. 29(2). 179–184. 25 indexed citations
18.
Nativ, Omri, Sarel Halachmi, Boaz Moskovitz, & Ofer Nativ. (2012). Treatment of Post, High-Intensity-Focused Ultrasound Urethral Stricture with Novel Long-term Stent. UroToday International Journal. 5(1). 1 indexed citations
19.
Abassi, Zaid, Omri Nativ, Hoda Awad, et al.. (2012). Urinary NGAL and KIM-1: Biomarkers for Assessment of Acute Ischemic Kidney Injury Following Nephron Sparing Surgery. The Journal of Urology. 189(4). 1559–1566. 29 indexed citations
20.
Halachmi, Sarel, et al.. (1995). Successful Treatment ofPostretroperitoneal LymphNode Dissection in MassiveChylous Ascites. European Urology. 28(2). 119–121. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kinga Musiał Breakdown of academic impact, for papers by Artur A. Antoniewicz Breakdown of academic impact, for papers by Yoko Azuma Breakdown of academic impact, for papers by Nathan Susnik Breakdown of academic impact, for papers by Manakan B. Srichai Breakdown of academic impact, for papers by Shuiming Guo Breakdown of academic impact, for papers by Said Movahedi Naini Breakdown of academic impact, for papers by Stone Yang Breakdown of academic impact, for papers by Giuseppe Carrieri Breakdown of academic impact, for papers by Hongya Han
Rankless by CCL
2026